BRCA1 and Alzheimer disease: To determine whether BRCA1 is altered in humans with AD, we immunostained post-mortem brain sections from people who had no cognitive deficits and a Braak score of 0 (controls) and from patients with mild cognitive impairment (MCI) or AD with an antibody against BRCA1.